Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia
about
Sequence and analysis of the genome of the pathogenic yeast Candida orthopsilosisRapid identification of medically important Candida isolates using high resolution melting analysisMultiple Origins of the Pathogenic Yeast Candida orthopsilosis by Separate Hybridizations between Two Parental SpeciesEvaluation of Fluorescent Capillary Electrophoresis for Rapid Identification of Candida Fungal InfectionsFungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.Uncommon opportunistic yeast bloodstream infections from Qatar.Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.The Genomic Aftermath of Hybridization in the Opportunistic Pathogen Candida metapsilosisSimple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism AnalysisMolecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014.Factors related to outcome of bloodstream infections due to Candida parapsilosis complexIdentification of Non-Coding RNAs in the Candida parapsilosis Species Group.Candidiasis in Pediatrics; Identification and In vitro Antifungal Susceptibility of the Clinical IsolatesA case of Candida orthopsilosis associated septic arthritis in a patient with Systemic Lupus Erythematosus (SLE)Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit.Identification and differentiation of Candida parapsilosis complex species by use of exon-primed intron-crossing PCR.An Italian consensus for invasive candidiasis management (ITALIC).The Candida pathogenic species complex.MTL genotypes, phenotypic switching, and susceptibility profiles of Candida parapsilosis species group compared to Lodderomyces elongisporus.Metabolic profiles of planktonic and biofilm cells of Candida orthopsilosis.Molecular identification and antifungal susceptibility profiles of Candida parapsilosis complex species isolated from culture collection of clinical samples.Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?Fungemia caused by Candida species in a children's public hospital in the city of São Paulo, Brazil: study in the period 2007-2010.Microbial epidemiology of candidemia in neonatal and pediatric intensive care units at Children's Medical Center, Tehran.Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae.Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12.Microsatellite genotyping clarified conspicuous accumulation of Candida parapsilosis at a cardiothoracic surgery intensive care unit.Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species.Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne mComparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts.Accurate identification of Candida parapsilosis (sensu lato) by use of mitochondrial DNA and real-time PCR.Ribosomic DNA intergenic spacer 1 region is useful when identifying Candida parapsilosis spp. complex based on high-resolution melting analysis.Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne methodCandidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility.Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates from clinical specimens at Siriraj Hospital, Thailand, from 2011 to 2015.Hybridization and emergence of virulence in opportunistic human yeast pathogens.Caries and Candida colonisation in adult patients in Basque Country (Spain).Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens.Comparison of commercial methods and the CLSI broth microdilution to determine the antifungal susceptibility of Candida parapsilosis complex bloodstream isolates from three health institutions in Rio de Janeiro, Brazil.
P2860
Q21561002-D89D9D78-9B96-4E8E-A319-2774BBD92B50Q28543415-63BAA4DB-B837-4B85-AD3F-86F04C5E84A9Q28822331-9CD48FD6-871A-481D-95FC-E014CB609652Q28834232-2DF4514D-5A86-4E9D-92DA-0D58D649D567Q30808061-E784F44F-2A64-4622-9746-22B3193C6BA3Q35189199-E3FF01DA-EC4F-45C2-9073-120D13C8916BQ35487439-C31DBD27-2560-46C1-85CD-16528BE86473Q35827279-18D683FC-EA6B-48D0-BFAB-3E445D18C8D0Q35845340-41591F78-FD95-4941-B291-FAC7CF3D11F5Q35937325-FDFEBF57-8201-4089-8428-4EA95A475455Q36099691-0BC1EB49-EF0B-46AD-9988-4B0CF4EBB9C1Q36141351-A776DB51-C10B-43A9-BBC0-B9736EDC4B4CQ36901716-7E86A2CF-7C55-41FE-A75E-7C65303E8565Q37009812-7BD018EF-647F-40C1-B861-1F504CEB80C8Q37192581-C9A9838E-2C33-49DE-9BA9-0AD498448FD1Q37713744-59988520-705E-4D68-A4DE-4611F7A921E9Q38165883-A547D6D5-B48F-4B8F-AF38-6F41E55F8919Q38245727-58A77FA1-4EB1-4533-A24D-647C27FDF33FQ38644323-F4330DD8-8F66-4E3E-8D5E-541ECDB6CDE6Q38818298-779CE8A1-75EC-45F9-AEFF-9A9A67F51EEFQ38882704-2E257EE0-17ED-48D9-BED7-DC34D9A9CDB1Q39033115-0BED721B-54B5-4C15-8ECF-99368B4B5B84Q39322474-207B1F5D-ED39-410A-8214-6E9DDD184799Q40057634-F144F4D8-1265-4E3E-8F14-2EAE43459C3BQ40640348-FCE2DDDF-D830-481C-B89C-A2710E3310A3Q41564139-A941B658-22B1-4B27-A236-0775DF3B5C11Q41579839-FF1053DE-A006-4B3E-8EB6-B4FE093F1190Q41613426-E542E2BC-EFC5-42E9-8E8F-589449B59657Q41640129-5B22568C-DB7B-4D6A-A312-1CE3BA74FFC6Q41868077-D68483F7-7189-4522-A16E-F06439AF6601Q42113240-2F1B62F6-55B6-4BE9-AF3E-C5DF636E1F27Q42214488-BF91141E-A310-4A3D-9C2A-F17E4FF48091Q42223395-33590266-A8A9-406E-BA73-6306DF8FE514Q42710734-CD8BAAEB-5D88-48B5-901C-240AE5AAAD46Q44768623-3D7A976D-C970-45B2-A7C1-AD49FCAFD0B5Q46290886-9EA662B6-A2CA-41EB-82A0-885BA0BF8E82Q46339999-295CC705-F08D-42A6-82C0-4DAE71B4EF00Q46611987-9AABEC2A-B0E5-4D76-9F04-1CCCB4640EADQ46705972-BC88295D-2548-4D88-A567-1F666C77C5ADQ46876146-8DC545D1-EF7F-445C-ACCB-4219F770F0A6
P2860
Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prospective multicenter study ...... from patients with candidemia
@ast
Prospective multicenter study ...... from patients with candidemia
@en
Prospective multicenter study ...... from patients with candidemia
@nl
type
label
Prospective multicenter study ...... from patients with candidemia
@ast
Prospective multicenter study ...... from patients with candidemia
@en
Prospective multicenter study ...... from patients with candidemia
@nl
prefLabel
Prospective multicenter study ...... from patients with candidemia
@ast
Prospective multicenter study ...... from patients with candidemia
@en
Prospective multicenter study ...... from patients with candidemia
@nl
P2093
P2860
P50
P356
P1476
Prospective multicenter study ...... from patients with candidemia
@en
P2093
Carmen Pazos
Carmen Rubio
Consuelo Miranda
David Velasco
Elia Gomez G de la Pedrosa
Emilia Cantón
FUNGEMYCA Study Group
Genoveva Yagüe
Ilargi Miranda-Zapico
Isolina Campos-Herrero
P2860
P304
P356
10.1128/AAC.00466-11
P407
P577
2011-09-19T00:00:00Z